Crossref journal-article
Springer Science and Business Media LLC
Psychopharmacology (297)
Bibliography

M�ller-Spahn, F., Ackenheil, M., Albus, M., Botschev, C., Naber, D., & Welter, D. (1986). Neuroendocrine effects of clonidine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: Relations to psychopathology. Psychopharmacology, 88(2), 190–195.

Authors 6
  1. F. M�ller-Spahn (first)
  2. M. Ackenheil (additional)
  3. M. Albus (additional)
  4. C. Botschev (additional)
  5. D. Naber (additional)
  6. D. Welter (additional)
References 40 Referenced 16
  1. Ackenheil M, Fr�hler M, Goldig G, Rall C, Welter D (1982) Catecholaminbestimmung im Blut und Liquor mit Hochdruckfl�ssigkeitschromatographie und elektrochemischem Detektor. Arzneimittel-Forschung/Drug Research, 32 (II), No 8, 893 / Arzneimittel-Forschung/Drug Research by M Ackenheil (1982)
  2. Albus M, Ackenheil M, Engel R, M�ller F (1982) Situational reactivity of autonomic functions in schizophrenic patients. Pschiatr Res 6:361?371 (10.1016/0165-1781(82)90026-9) / Pschiatr Res by M Albus (1982)
  3. And�n NE, Corrodi H, Fuxe K et al. (1970) Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci 9:513?523 (10.1016/0024-3205(70)90207-9) / Life Sci by NE And�n (1970)
  4. B�rki HR, Ruch W, Asper H, Baggiolini M, Stille G (1974) Effect of single and repeated administration of clozapine on the metabolism of dopamine and noradrenaline in the brain of the rat. Eur J Pharmacol 27:180?190 (10.1016/0014-2999(74)90144-7) / Eur J Pharmacol by HR B�rki (1974)
  5. Burt DR, Creese I, Snyder SH (1977) Antischizophrenic drugs: Chronic treatment elevates dopamine receptor binding in brain. Science 196:326?328 (10.1126/science.847477) / Science by DR Burt (1977)
  6. Creese I (1983) Receptor interactions of neuroleptics. In: Coyle JT, Enna SJ (eds) Neuroleptics: neurochemical, behavioral, and clinical perspectives, Raven Press, pp 183?222
  7. Cross AJ, Crow TJ, Killpack WS, Longden A, Owen F, Riley GJ (1978) The activities of brain dopamine-?-hydroxylase and catechol-0-methyl transferase in schizophrenics and controls. Psychopharmacology 59:117?121 (10.1007/BF00427744) / Psychopharmacology by AJ Cross (1978)
  8. Crow TJ (1982) Two dimensions of pathology in schizophrenia: dopaminergic and non-dopaminergic. Psychopharmacol Bull 18 (3):22?29 / Psychopharmacol Bull by TJ Crow (1982)
  9. Davis JM (1976) Recent developments in the drug treatment of schizophrenia. Am J Psychiatry 133:208?214 (10.1176/ajp.133.2.208) / Am J Psychiatry by JM Davis (1976)
  10. Davis JM, Cole JO (1975) Antipsychotic drugs. In: Freedman AM, Kaplon HI, Sadock BJ (eds) Comprehensive textbook of psychiatry, vol 2 Williams and Wilkins, Baltimore, pp 1921?1941 / Comprehensive textbook of psychiatry, vol 2 by JM Davis (1975)
  11. Gattaz WF, Riederer P, Reynolds GP, Gattaz D, Beckmann H (1983) Dopamine and noradrenaline in the cerebrospinal fluid of schizophrenic patients. Psychiatr Res 8:243?250 (10.1016/0165-1781(83)90012-4) / Psychiatr Res by WF Gattaz (1983)
  12. Gomes UCR, Shanley BC, Potgieter L, Roux JT (1980) Noradrenergic overactivity in chronic schizophrenia: Evidence based on cerebrospinal fluid noradrenaline and cyclic nucleotide concentrations. Br J Psychiatry 137:346?351 (10.1192/bjp.137.4.346) / Br J Psychiatry by UCR Gomes (1980)
  13. Gro� G, Sch�mann HJ (1980) Enhancement of noradrenaline release from rat cerebral cortex by neuroleptic drugs. Arch Pharmacol 315:103?109 (10.1007/BF00499252) / Arch Pharmacol by G Gro� (1980)
  14. Hjemdahl P, Daleskog M, Kahan T (1979) Determination of plasma catecholamines by HPLC with electrochemical detection. Comparison with a radioenzymatic method. Life Sci 25:131?138 (10.1016/0024-3205(79)90384-9) / Life Sci by P Hjemdahl (1979)
  15. Kleinman JE, Bridge P, Karoum F, Speciale S, Staub R, Zalcman S, Gillin J, Wyatt R (1980) Chronic schizophrenia: postmortem studies. In: Baxter C, Melnechuk T (eds) Perspectives in schizophrenia research. Raven Press, N.Y. pp 227?233 / Perspectives in schizophrenia research by JE Kleinman (1980)
  16. Lake CR, Sternberg DE, van Kammen DP, Ballenger JC, Ziegler MG, Post RM, Kopin IJ, Bunney WE (1980) Schizophrenia: Elevated cerebrospinal fluid norepinephrine. Science 207:331?333 (10.1126/science.7350667) / Science by CR Lake (1980)
  17. Lal S, Tolis G, Martin JB, Brown GM, Guyda H (1975) Effect of clonidine on growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone and thyroid-stimulating hormone in the serum of normal men. J Clin Endocrinol Metab 41:827?832 (10.1210/jcem-41-5-827) / J Clin Endocrinol Metab by S Lal (1975)
  18. Lal S, Nair NPV, Thavundayil JX, Monks RC, Guyda H (1983) Clonidine-induced growth hormone secretion in chronic schizophrenia. Acta Psychiatr Scand 68:82?88 (10.1111/j.1600-0447.1983.tb06985.x) / Acta Psychiatr Scand by S Lal (1983)
  19. Maany I, Frazer A, Mendels J (1974) Apomorphine: Effect on growth hormone. J Clin Endocrinol Metab 40:162?163 (10.1210/jcem-40-1-162) / J Clin Endocrinol Metab by I Maany (1974)
  20. Maas JW, Landis DH (1968) In vivo studies of the metabolism of norepinephrine in the central nervous system. J Pharmacol Exp Ther 163:147?162 / J Pharmacol Exp Ther by JW Maas (1968)
  21. Martres MP, Costenin J, Baudry M, Marcais H, Protais P, Schwartz JC (1977) Long-term changes in the sensitivity of pre- and postsynaptic dopamine receptors in mouse striatum evidenced by behavioral and biochemical studies. Brain Res 136:319?337 (10.1016/0006-8993(77)90806-X) / Brain Res by MP Martres (1977)
  22. Matthysse S (1973) Antipsychotic drug actions: a clue to the neuropathology of schizophrenia? Fed Proc 32:200?205 / Fed Proc by S Matthysse (1973)
  23. Matussek M, Ackenheil M, Hippius H, M�ller F, Schr�der HTh, Schultes H, Wasilewski B (1980) Effect of clonidine on growth hormone release in psychiatric patients and controls. Psychiatr Res 2:25?36 (10.1016/0165-1781(80)90004-9) / Psychiatr Res by M Matussek (1980)
  24. Merim�e TJ, Fineberg SE (1971) Studies on the sex based variation of human growth hormone secretion. J Clin Endocr 33:896?902 (10.1210/jcem-33-6-896) / J Clin Endocr by TJ Merim�e (1971)
  25. M�ller-Spahn F, Ackenheil M, Albus M, May G, Naber D, Welter D, Zander K (1984) Neuroendocrine effects of apomorphine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: Relations to psychopathology and tardive dyskinesia. Psychopharmacology 84:436?440 (10.1007/BF00555228) / Psychopharmacology by F M�ller-Spahn (1984)
  26. Naber D, Finkbeiner C, Fischer B, Zander KJ, Ackenheil M (1980) Effect of long-term neuroleptic treatment on prolactin and norepinephrine levels in serum of chronic schizophrenics: relations to psychopathology and extrapyramidal symptoms. Neuropsychobiology 6:181?189 (10.1159/000117751) / Neuropsychobiology by D Naber (1980)
  27. Naber D, M�ller F (1984) Effects of long-term neuroleptic treatment on serum levels of prolactin, TSH, LH and norepinephrine and on alpha-adrenergic and dopaminergic receptor sensitivity. Relations to tardive dyskinesia. In: Shah NS, Donald AH (eds). Plenum Publishing Corporation, pp 599?612
  28. Overall JE, Gorham DR (1976) Brief Psychiatric Rating Scale. In: Guy W (ed) ECDEU. Assessment Manual for Psychopharmacology, (Rev Ed Rockville, Maryland) pp 157?169
  29. Peroutka SJ, U'Prichard DC, Greenberg DA, Snyder SH (1977) Neuroleptic drug interactions with norepinephrine alpha-receptor binding sites in rat brain. Neuropharmacology 16:549?556 (10.1016/0028-3908(77)90023-5) / Neuropharmacology by SJ Peroutka (1977)
  30. Pradhan SN, Bose S (1978) Interactions among central neurotransmitters. In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology: a generation of progress, Raven Press, N.Y. pp 271?281 / Psychopharmacology: a generation of progress by SN Pradhan (1978)
  31. Rudolph CD, Kaplan SL, Ganong WF (1980) Sites at which clonidine acts to affect blood pressure and the secretion of renin, growth hormone and ACTH. Neuroendocrinology 31:121?128 (10.1159/000123062) / Neuroendocrinology by CD Rudolph (1980)
  32. Sarafoff M, Davis L, R�ther E (1979) Clozapine induced increase of human plasma norepinephrine. J Neural Transm 46:175?180 (10.1007/BF01250337) / J Neural Transm by M Sarafoff (1979)
  33. Scatton B (1980) Effect of repeated treatment with neuroleptics on dopamine metabolism in cell bodies and terminals of dopaminergic systems in the rat brain. Biochem Psychopharmacol 24:31?36 / Biochem Psychopharmacol by B Scatton (1980)
  34. Seeman P (1981) Brain dopamine receptors. Pharmacol Rev 32:229?313 / Pharmacol Rev by P Seeman (1981)
  35. Sternberg DE, van Kammen DP, Lake ChR, Ballenger JC, Marder StR, Bunney WE (1981) The effect of pimozide on CSF norepinephrine in schizophrenia. Am J Psychiatry 138:1045?1051 (10.1176/ajp.138.8.1045) / Am J Psychiatry by DE Sternberg (1981)
  36. Sternberg DE, Charney DS, Heninger GR, Leckman JF, Hafstad KM, Landis DH (1982) Impaired presynaptic regulation of norepinephrine in schizophrenia. Arch Gen Psychiatry 39:285?289 (10.1001/archpsyc.1982.04290030025004) / Arch Gen Psychiatry by DE Sternberg (1982)
  37. Valchar M, Metysova J, Chlebounova J, Dlabac A (1982) Induction of dopaminergic supersensitivity after a single dose of the neuroleptic isofloxythepin. Psychopharmacology 76:381?384 (10.1007/BF00449129) / Psychopharmacology by M Valchar (1982)
  38. Venables PH (1977) The electrodermal psychophysiology of schizophrenics and children at risk for schizophrenia: controversies and developments. Schizophr Bull 3(1):28?48 (10.1093/schbul/3.1.28) / Schizophr Bull by PH Venables (1977)
  39. Weinreich P, Seeman P (1981) Binding of adrenergic ligands (3H) clonidine and (3H) WB 4101 to multiple sites in human brain. Biochem Pharmacol 30:3115?3120 (10.1016/0006-2952(81)90502-5) / Biochem Pharmacol by P Weinreich (1981)
  40. Zander KJ, Fischer B, Zimmer R, Ackenheil M (1981) Long-term neuroleptic treatment of chronic schizophrenic patients: clinical and biochemical effects of withdrawal. Psychopharmacology 73:43?47 (10.1007/BF00431099) / Psychopharmacology by KJ Zander (1981)
Dates
Type When
Created 20 years, 9 months ago (Nov. 28, 2004, 8:22 p.m.)
Deposited 6 years, 4 months ago (April 9, 2019, 8:45 a.m.)
Indexed 11 months, 3 weeks ago (Sept. 12, 2024, 12:35 p.m.)
Issued 39 years, 8 months ago (Jan. 1, 1986)
Published 39 years, 8 months ago (Jan. 1, 1986)
Published Print 39 years, 8 months ago (Jan. 1, 1986)
Funders 0

None

@article{M_ller_Spahn_1986, title={Neuroendocrine effects of clonidine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: Relations to psychopathology}, volume={88}, ISSN={1432-2072}, url={http://dx.doi.org/10.1007/bf00652239}, DOI={10.1007/bf00652239}, number={2}, journal={Psychopharmacology}, publisher={Springer Science and Business Media LLC}, author={M�ller-Spahn, F. and Ackenheil, M. and Albus, M. and Botschev, C. and Naber, D. and Welter, D.}, year={1986}, pages={190–195} }